Important: New Login Process
We've updated our access and security system. The first time you log in, enter your work email, and we'll guide you through the process.
- If your organization uses Single Sign-On (SSO), you will be redirected to your company's login portal.
- If you log in with a username and password, you will be prompted to set a new password before accessing your account.
Go to the Login Page to get started.
We appreciate your cooperation during this transition. If you need assistance, please call +1 650-552-4224 or email support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Eiger Biopharmaceuticals Inc.
Headquarters: Palo Alto, CA, United States of America
Website: N/A
Year Founded: 2008
Status: Out of Business
BioCentury | Sep 26, 2024
Management Tracks
Draghia-Akli, a veteran of J&J and Merck, joins Novavax as head of R&D
Plus: Septerna expands clinical team and an update from AAM
BioCentury | Jun 25, 2024
Deals
Deals Report: Roche licenses Ascidian’s RNA editing tech for neuro
Plus: Day One adds PTK7 ADC from MabCare, and updates from Sanofi-Belharra and more
BioCentury | May 7, 2024
Deals
Deals report: Novartis strengthens radiotherapy pipeline with pair of deals
Plus: Xyphos-Poseida to develop allogeneic CAR T therapies, Chiesi gains ex-U.S. right to Gossamer’s seralutinib, and more
BioCentury | Feb 21, 2024
Management Tracks
Papa succeeds Miller as Emergent’s CEO
Plus: Paratus names Heah as CEO and updates from Jazz, Arvinas, KaliVir, Celcuity, QuidelOrtho, Turnstone and PhRMA
BioCentury | Dec 8, 2023
Management Tracks
Shorla names new chief commercial officer
Plus: Santhera promotes van Daal and Schrader, and updates from Treadwell, LIB, Rentschler and Avalere
BioCentury | Sep 13, 2023
Management Tracks
CEO Nick Leschly shifting to chair as 2seventy bio restructures
Plus: CFO Galá promoted at Jazz, and updates from Geron, Mirum, ReNAgade,
BioCentury | Jan 23, 2023
Management Tracks
Ryali becomes CFO of Codexis
Plus: Levisetti made CMO at Cue, and updates from Qu and Biocrucible
BioCentury | Dec 9, 2022
Finance
Dec. 8 Quick Takes: ADC play Dantari debuts with $47M led by Westlake
Plus: Sanofi ends SHP2 deal with Revolution and updates from Novartis, Daiichi, Takeda, Autolus, C-PATH and more
BioCentury | Oct 6, 2022
Regulation
Oct. 5 Quick Takes: Eiger won’t submit EUA for COVID-19 candidate
Plus Global Blood now part of Pfizer, and updates from Araris, Valitor, Connect and more
BioCentury | Sep 6, 2022
Regulation
Sept. 6 Quick Takes: FDA lifts clinical hold on Sarepta DMD trial
Plus Arsenal raises $220M and updates from Roche, Phoremost, Synlogic and more
Items per page:
1 - 10 of 61